Abraxis, Protocol No.: CA033,
Laufzeit: 01.01.2010 - 31.12.2011
imported
Kurzfassung
An open-label, multicenter, Phase III Trial of ABI-007 vs Dacarbazine in previously untrested patients with metastatic malignant melanoma
Laufzeit: 01.01.2010 - 31.12.2011
An open-label, multicenter, Phase III Trial of ABI-007 vs Dacarbazine in previously untrested patients with metastatic malignant melanoma
